System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Jillian S Y Lau, MBBS, PhD is an expert in Infectiology at Peter Doherty Institute (Australia). Jillian S Y Lau has authored 56 publications, the most recent in 2026, and is an investigator in 5 clinical trials, 2 of them ongoing. SLR score: 229 (community average: 125). How the SLR is computed.

LeadR Profile

Jillian S Y Lau, MBBS, PhD Peter Doherty Institute Australia
229 ScienceLeadR Reputation 229

Unlock

Register Login
Network Map

Infectiology

Subspecialties: Immunology - Internal Medicine - Biochemistry

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2016 - 2026
Source: PubMed

Peter Doherty Institute

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 56

Citations

Citations: 1 674 1st author: 17 Last author: 10 Unique author: 1

Main journals

AIDS 3
AIDS Res Hum Retroviruses 3
Clin Infect Dis 3
Intern Med J 3
Antibiotics (Basel) 2

Best Journals

JAMA 1
N Engl J Med 1
Nat Med 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Cefazolin for Methicillin-Susceptible Staphylococcus aureus Bacteremia.
PMID 42308484 — bacteremia, staphylococcus, mortality, probability, kidney, floxacillin, odds ratio, cefazolin, staphylococcus aureus, acute kidney injury, methicillin, cloxacillin		N Engl J Med Top journal202614
Knowledge and attitudes about solid organ transplantation for people with human immunodeficiency virus among Australian healthcare providers: a cross-sectional survey.
PMID 41395743 — comorbidity, cross-sectional studies, internal medicine, hiv, viruses, health personnel, organ transplantation, transplantation		Intern Med J20251
From initial awareness to sustained involvement: using social and behavioral stage models to better understand engagement in HIV cure efforts in the Netherlands, France, Australia, and sub-saharan Africa.
PMID 41312896 — hiv, work, research, physical exertion		AIDS Care20250
Long-Term Outcomes Following Suppressive Antibiotic Therapy: A 10-Year Cohort Study.
PMID 41301659 — comorbidity, cohort studies, therapeutics, infections		Antibiotics (Basel)20250
HIV and the gut: implications for HIV persistence, immune dysfunction and cure strategies.
PMID 41050701 — cells, hiv, immunity, mucosal, immune system diseases, therapeutics		Front Immunol20250

Clinical Studies 5

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

Phase 2 2
N/A 1
Phase 3 1
Phase 4 1

By status:

Recruiting 2
Active not recruiting 1
Completed 1
Unknown 1

By type:

Interventional 4
Observational 1

By Monocentric/Multicentric:

monocentric 2
multicentric2to4 0
multicentric5to9 1
multicentricup10 2

Main Topics

Ongoing Clinical Trials

2 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Optimising Cohorts for HIV Cure Interventions
NCT05852301 — cd4 lymphocyte count, cells, hiv-1, hiv, cell count, t-lymphocytes, infections		N/ARecruiting2023
Staphylococcus Aureus Network Adaptive Platform Trial
NCT05137119 — bacteremia, research design, quality control, staphylococcal infections, methicillin-resistant staphylococcus aureus, clindamycin, staphylococcus, radiopharmaceuticals, penicillins, lincomycin, positron emission tomography computed tomography, penicillin g, vancomycin, cefazolin, staphylococcus aureus, methicillin, infections, daptomycin		Phase 4Recruiting2022

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS